MS HC37

Recognizes the week of May 1-7, 2022, as "Tardive Dyskinesia (TD) Awareness Week" throughout Mississippi to promote effective diagnosis and treatment of the disorder.

Identifies Tardive Dyskinesia as a movement disorder characterized by involuntary, uncontrolled movements that can develop months, years, or decades after starting dopamine receptor blocking agent medications like antipsychotics.

Notes that over 600,000 Americans suffer from TD, with approximately one in four patients on long-term antipsychotic treatment experiencing the condition, and that TD is often unrecognized and misdiagnosed.

Acknowledges recent FDA approval of two new treatments for TD and recommends regular screening by the American Psychiatric Association for patients taking DRBA medications.

Encourages Mississippi citizens to become better informed about Tardive Dyskinesia and directs distribution of the resolution to the State Board of Health and Capitol Press Corps.